Central Admixture Pharmacy Services Inc

FDA recalling firm · 10 enforcement events · 347 product records · 2014–2026 · PA, AZ

Central Admixture Pharmacy Services Inc has 10 FDA enforcement events on this register (347 product records) between 2014 and 2026: 10 drug; the busiest year was 2023 with 5.

30% of its events are Class I; the most common class is Class II (6). 3 events are listed as ongoing; the recalling firm's address is in PA and AZ.

Recall classification reflects the relative degree of health hazard. Event counts depend on a firm's size and product range; they are not a comparison of one firm with another.

Enforcement events

Initiated	Product (first record)	Type	Class	Records	Status
16 Jul 2026	Total Parental Nutrition - Pediatric PN Patient-Specific TPN Bag, (patient specific), Compound Volume 416.8 mL per bag, Rx only, Single Dose Injection, Refrigerated Injection, Central Admixture Pharmacy Services, Inc., Atlanta, 1750 Corp Dr. Ste 725, Norcross, GA 30093 (844) 903-6418	Drug	Class III	1	Ongoing
2 Jun 2026	Total Parental Nutrition - Pediatric PN Patient-Specific TPN Bag, (patient specific), Rx# 24-1269856-0-1Compound Volume 1295 mL per bag, Rx only, Single Dose Injection, Refrigerated Injection, Central Admixture Pharmacy Services, Boston, 55 6th Rd Woburn, Massachusetts 01801-1767.	Drug	Class II	1	Ongoing
20 Feb 2025	PHENYLephrine added to 0.9% sodium chloride, 40 mg/250 mL* (160 mcg/mL), Rx Only, CAPS, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, 855-275-2270, NDC 71285-6092-1.	Drug	Class I	1	Ongoing
21 Sep 2023	fentaNYL in 0.9% sodium chloride, 10 mcg/1 mL, (10 mcg/mL), 3 mL syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2071-7	Drug	Class II	32	Terminated
17 Aug 2023	CARDIOPLEGIA SOLUTION, 20 mEq K, Maintenance 4:1, Low Potassium, Total Volume = 810 mL, EVA Bag, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043, NDC: 72196-0103-1	Drug	Class II	32	Terminated
17 Jul 2023	fentaNYL in dextrose 5%, 300 mcg/30 mL, (10 mcg/mL), 30 mL syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C San Diego, CA 92126, NDC: 71286-2001-2	Drug	Class II	39	Terminated
14 Jul 2023	rocuronium50 mg/5 mL (10 mg/mL), Syringes Rx only, this drug was repackaged by CAPS Inc, 2200 South 43rd Avenue, Pheonix, AZ, NDC 72196-6010-1.	Drug	Class II	95	Terminated
28 Apr 2023	Microplegia (MSA/MSG 0.92 Molar) packaged in 125 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0001-1.	Drug	Class II	108	Terminated
17 Dec 2014	University of Alabama Birmingham TPN Neonatal Starter Bag, compound vol: 100 ml, Trophamine 4% Dextrose 10%, sterile injectable, Rx only, compounded drug, IV infusion bag packaged in a corrugated box. each container is lined with a polystyrene insert; CAPS, Allentown, PA	Drug	Class I	34	Terminated
28 May 2014	PEDIATRIC CARDIOPLEGIA, 255 mL, Rx Only, Central Admixture Pharmacy Services, Inc., Livonia, MI 48150	Drug	Class I	4	Terminated

By type and class

Drug10

Class II6

Class I3

Class III1

Class I: 30% of this firm's events; 18% of all events on the register.

Events by year

Enforcement events for Central Admixture Pharmacy Services Inc by year initiated.

Questions and answers

How many FDA recalls has Central Admixture Pharmacy Services Inc had?

10 enforcement events (347 product records) on this register, 2014–2026: 10 drug.

Are any Central Admixture Pharmacy Services Inc recalls ongoing?

3 events are listed as ongoing in the current openFDA export.

What class are Central Admixture Pharmacy Services Inc recalls?

6 Class II, 3 Class I, 1 Class III. 30% are Class I against 18% of all events on the register. Class reflects the relative degree of health hazard of the product, not the firm.

Where does this data come from?

openFDA food, drug and device enforcement reports (CC0), export dated 28 Sep 2026.

Provenance

Source: openFDA enforcement reports (CC0), export dated 28 Sep 2026. Firm names are grouped exactly as FDA spells them; the same company can appear under several spellings. Only organisations are shown. See the methodology.